PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation
Recruiting
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT05009797
- Lead Sponsor
- University Hospital, Lille
- Brief Summary
Atrial fibrillation ablation is the most common intervention performed worldwide. Up to 20 to 45% of patients show recurrence of AF within 12 month after catheter ablation, however its determinant are incompletely understood.
The aim of the PROSPECT-AF study is to assess the predictors of AF recurrence within the 3 years following ablation using clinical variables and innovative biomarkers in a prospective cohort of 750 patients undergoing atrial fibrillation catheter ablation.
The secondary aims are to assess the incidence of major adverse cardiovascular outcomes (MACE) and the incidence of major bleeding within the 3 years Wolfing catheter ablation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 750
Inclusion Criteria
- Patient undergoing atrial fibrillation catheter ablation
- Able to give their consent
Exclusion Criteria
- Childs
- Patient under guardianship
- Patients unable to give their consent
- Pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of atrial fibrillation recurrence. At 3 years
- Secondary Outcome Measures
Name Time Method Incidence of major adverse cardiovascular events (MACE) including hospitalization for acute heart failure, cardiovascular death, stroke, myocardial infarction At 3 years Incidence of major bleeding (defined by BARC≥3 bleeding) At 3 years
Trial Locations
- Locations (1)
Institut Coeur-Poumon, CHU
🇫🇷Lille, France
Institut Coeur-Poumon, CHU🇫🇷Lille, France